Skip to main content
hpa logo
Topics A-Z:
Search the site:
Home › Products & Services › Chemicals & Poisons › International Activities ›Alerting System for Chemical Health Threats Phase II (ASHTII) ›  ASHTII Work Packages
Printer friendly page (opens in new window)

ASHTII Work Packages

WP1: Project co-ordination

Lead: HPA

WP1 covers the coordination and technical management of the project to ensure that all deliverables are met. The HPA are responsible for delivery of the financial and contractual obligations of the contract on behalf of the Commission.

WP2: Dissemination of Results

Lead: EAPCCT

The primary objective of WP2 is to encourage and support the use and testing of the EUPC forum and RAS-CHEM. Rasing awareness of the systems and engaging National Public Health Officials (NPHO) and EU Poison Centres is key to the future EU implementation of the system.

WP3: Evaluation of the Project

Lead: HPA

WP3 covers the continual evaluation of the project to fulfil each of the outlined objectives. Each objective carries and indicator of performance which will be systematically addressed throughout the contract.

WP4: Development of a European Wide Poison Centre Forum

Lead: UMG-GOE

WP4 objectives are: to perform a comprehensive analysis of the requirements of a web based forum that would allow EU Poisons to exchange information readily; develop and test the effectiveness of the pilot IT system.

WP5: Identify Core Information required at Ministerial Level for Liaison with National Public Health Authorities

Lead: HPA

The HPA will coordinate WP5 in close collaboration with the project partners to understand the structure and strategies for engaging NPHOs in different countries. Raising awareness and promoting future participation of NPHOs in the project is also key.

WP6: Harmonisation of Toxic Chemicals Agents, Clinical Features and Syndromes Following Exposure to these Agents

Lead: GFH

The objective of WP6 is to produce a harmonised classification system and list of definitions of toxic agents or chemicals in conjunction with consensually agreed clinical terminology of features and symptoms/syndromes that would signal possible release or exposure to these toxic agents.

WP7: Further Development of RAS-CHEM

Lead: UMG-GOE

UMG-GOE will lead WP7 to ensure: that the EUPC-forum (WP4) and RAS-CHEM are interoperable systems; the outputs from WP5 and WP6 are incorporated into RAS-CHEM. Participation and raising awareness of the system is key, along with comprehensive testing of the system.


Last reviewed: 9 March 2010